Our observation that there is a positive correlation between IFN-γ -stimulated STAT1 phosphorylation level in circulating lymphocytes and treatment response to biological drugs in patients with chronic RA may reflect an overall immunological state that is facilitated by good STAT1 activation capability. This evidence concerns the gene IFNG and rheumatoid arthritis.